Cameron Siddens, MD
Endocrinology, Diabetes & Metabolism · Colorado Springs, CONPI 1356787436
Payments from drug & device makers
Across 16 payments — averaging $57.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tandem Diabetes Care, Inc.$421
- Insulet Corporation$150
- Amgen$106
- Amphastar Pharmaceuticals, Inc.$74
- Dexcom, Inc.$70
- Abbott$60
- plus $36 from 2 others
What the payments were for
- Speaking & faculty fees$30033%
- Food & beverage$55761%
- Education$607%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tandem Diabetes Care, Inc. | 5 | $421 |
| Insulet Corporation | 3 | $150 |
| Amgen | 1 | $106 |
| Amphastar Pharmaceuticals, Inc. | 1 | $74 |
| Dexcom, Inc. | 3 | $70 |
| Abbott | 1 | $60 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Medtronic | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- t-slim insulin pump$300
- Prolia$106
How this compares
$917 in reported general payments places this provider in the 40th percentile of 120 endocrinology, diabetes & metabolism providers in Colorado.
See all endocrinology, diabetes & metabolism providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ForteoTeriparatide | 28 | $127,158 |
| TrulicityDulaglutide | 79 | $119,691 |
| OzempicSemaglutide | 63 | $82,783 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 36 | $80,160 |
| Somatuline DepotLanreotide Acetate | 12 | $75,065 |
| MounjaroTirzepatide | 46 | $72,596 |
| Tresiba Flextouch U-200Insulin Degludec | 18 | $46,086 |
| Teriparatide | 17 | $43,072 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $26,091 |
| JardianceEmpagliflozin | 17 | $24,536 |
| Humalog Kwikpen U-200Insulin Lispro | 12 | $24,439 |
| Tresiba Flextouch U-100Insulin Degludec | 22 | $21,183 |
| FarxigaDapagliflozin Propanediol | 11 | $17,923 |
| Novolog FlexpenInsulin Aspart | 39 | $11,918 |
| Humalog Kwikpen U-100Insulin Lispro | 27 | $10,222 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Colorado Springs
- Christina BratcherColorado Springs$23K
- Susan HenleyColorado Springs$9K
- Satish GargAurora$8.6M
- Neda RasouliAurora$6.7M
- Viralkumar ShahAurora$2.1M
- Halis AkturkAurora$1.8M
- Leigh PerreaultBoulder$1.7M
- Daniel BessesenDenver$1.2M
- Lori GerardEnglewood$786K
- Leonard ZemelDenver$728K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.